Trademark Overview
On Monday, February 24, 2025, a trademark application was filed for ANKTIGEN with the United States Patent and Trademark Office. The USPTO has given the ANKTIGEN trademark a serial number of 99053158. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, February 24, 2025. This trademark is owned by ImmunityBio, Inc.. The ANKTIGEN trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment and prevention of lymphopenia; Pharmaceutical preparations for the treatment and prevention of immunosuppressive side effects of chemotherapy, radiotherapy, and pathogenic infections; Pharmaceutical preparations for use in stimulating lymphocyte production; Pharmaceutical preparations for maintenance of lymphocyte counts